Literature DB >> 30478509

Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals.

Francesca Viazzi1, Giuseppina Tiziana Russo2, Antonio Ceriello3,4, Paola Fioretto5, Carlo Giorda6, Salvatore De Cosmo7, Roberto Pontremoli8.   

Abstract

The Associazione Medici Diabetologi (AMD) annals initiative is an ongoing observational survey promoted by AMD. It is based on a public network of about 700 Italian diabetes clinics, run by specialists who provide diagnostic confirmation and prevention and treatment of diabetes and its complications. Over the last few years, analysis of the AMD annals dataset has contributed several important insights on the clinical features of type-2 diabetes kidney disease and their prognostic and therapeutic implications. First, non-albuminuric renal impairment is the predominant clinical phenotype. Even though associated to a lower risk of progression compared to overt albuminuria, it contributes significantly to the burden of end-stage renal disease morbidity. Second, optimal blood pressure control provides significant but incomplete renal protection. It reduces albuminuria but there may be a J curve phenomenon with eGFR at very low blood pressure values. Third, hyperuricemia and diabetic hyperlipidemia, namely elevated triglycerides and low HDL cholesterol, are strong independent predictors of chronic kidney disease (CKD) onset in diabetes, although the pathogenetic mechanisms underlying these associations remain uncertain. Fourth, the long-term intra-individual variability in HbA1c, lipid parameters, uric acid and blood pressure plays a greater role in the appearance and progression of CKD than the absolute value of each single variable. These data help clarify the natural history of CKD in patients with type 2 diabetes and provide important clues for designing future interventional studies.

Entities:  

Keywords:  Albuminuria; Chronic kidney disease; Glomerular filtration rate; Hypertension; T2 diabetes

Year:  2018        PMID: 30478509     DOI: 10.1007/s40620-018-00561-3

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  40 in total

1.  Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.

Authors:  A Risso; F Mercuri; L Quagliaro; G Damante; A Ceriello
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-11       Impact factor: 4.310

2.  Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Authors:  Ravi Retnakaran; Carole A Cull; Kerensa I Thorne; Amanda I Adler; Rury R Holman
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

4.  Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study.

Authors:  G T Russo; J B Meigs; L A Cupples; S Demissie; J D Otvos; P W Wilson; C Lahoz; D Cucinotta; P Couture; T Mallory; E J Schaefer; J M Ordovas
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

5.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

Authors:  Toshiharu Ninomiya; Vlado Perkovic; Bastiaan E de Galan; Sophia Zoungas; Avinesh Pillai; Meg Jardine; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Stephen Macmahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

6.  Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.

Authors:  J Lin; F B Hu; C Mantzoros; G C Curhan
Journal:  Diabetologia       Date:  2009-11-18       Impact factor: 10.122

7.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

8.  Diabetic retinopathy in a multi-ethnic cohort in the United States.

Authors:  Tien Yin Wong; Ronald Klein; F M Amirul Islam; Mary Frances Cotch; Aaron R Folsom; Barbara E K Klein; A Richey Sharrett; Steven Shea
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).

Authors:  Merlin C Thomas; Richard J Macisaac; George Jerums; Andrew Weekes; John Moran; Jonathan E Shaw; Robert C Atkins
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 19.112

View more
  9 in total

1.  Association between anemia and mortality in hemodialysis patients is modified by the presence of diabetes.

Authors:  Yukio Maruyama; Eiichiro Kanda; Kan Kikuchi; Masanori Abe; Ikuto Masakane; Takashi Yokoo; Kosaku Nitta
Journal:  J Nephrol       Date:  2021-02-08       Impact factor: 3.902

2.  Plasma activity of the antioxidant enzymes in predicting diabetic nephropathy progression.

Authors:  Marijana Kovačević; Snežana Mališ; Dragana Pavlović; Maksim Kovačević; Ana Savić Radojević; Ljubica Djukanović
Journal:  Int Urol Nephrol       Date:  2021-10-16       Impact factor: 2.370

Review 3.  Variability of risk factors and diabetes complications.

Authors:  Antonio Ceriello; Francesco Prattichizzo
Journal:  Cardiovasc Diabetol       Date:  2021-05-07       Impact factor: 9.951

Review 4.  Glycemic variability: adverse clinical outcomes and how to improve it?

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Chunsheng Zhu; Meng Bian
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

5.  Artificial Intelligence and Big Data in Diabetes Care: A Position Statement of the Italian Association of Medical Diabetologists.

Authors:  Nicoletta Musacchio; Annalisa Giancaterini; Giacomo Guaita; Alessandro Ozzello; Maria A Pellegrini; Paola Ponzani; Giuseppina T Russo; Rita Zilich; Alberto de Micheli
Journal:  J Med Internet Res       Date:  2020-06-22       Impact factor: 5.428

Review 6.  Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.

Authors:  Bao Sun; Zhiying Luo; Jiecan Zhou
Journal:  Cardiovasc Diabetol       Date:  2021-01-07       Impact factor: 9.951

Review 7.  Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency.

Authors:  Le Deng; Wenjie Li; Gaosi Xu
Journal:  Eur J Med Res       Date:  2021-12-11       Impact factor: 2.175

8.  Risk Factors for Progression of CKD with and without Diabetes.

Authors:  Xiaohong Zhang; Yuan Fang; Zhenhuan Zou; Pianpian Hong; Yongjie Zhuo; Yanfang Xu; Jianxin Wan
Journal:  J Diabetes Res       Date:  2022-08-22       Impact factor: 4.061

Review 9.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.